Meridian Bioscience Inc logo

Meridian Bioscience Inc

$ 31.53 -0.38 (-1.19%) 10:08 PM EST
On watch
P/E:
32.17
P/B:
3.77
Market Cap:
$ 1.38B
Enterprise V:
$ 1.33B
Volume:
348.08K
Avg Vol (2M):
385.34K
Also Trade In:
Volume:
348.08K
Market Cap $:
1.38B
PE Ratio:
32.17
Avg Vol (2-Month):
385.34K
Enterprise Value $:
1.33B
PB Ratio:
3.77
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.
Name Current Vs Industry Vs History
Cash-To-Debt 2.63
Equity-to-Asset 0.79
Debt-to-Equity 0.09
Debt-to-EBITDA 0.42
Interest Coverage 54.64
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 10.44
Distress
Grey
Safe
Beneish M-Score -2.72
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 27.61
9-Day RSI 33.9
14-Day RSI 39.07
6-1 Month Momentum % 25.54
12-1 Month Momentum % 69.39

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.52
Quick Ratio 2.36
Cash Ratio 1.38
Days Inventory 183.87
Days Sales Outstanding 51.9
Days Payable 36.45

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Dividend Growth Rate -100
3-Year Average Share Buyback Ratio -0.8

Financials (Next Earnings Date:2022-11-11 Est.)

VIVO's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:VIVO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 343.547
EPS (TTM) ($) 0.98
Beta 0.26
Volatility % 23.07
14-Day RSI 39.07
14-Day ATR ($) 0.519408
20-Day SMA ($) 32.069
12-1 Month Momentum % 69.39
52-Week Range ($) 17.2 - 34.375
Shares Outstanding (Mil) 43.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Meridian Bioscience Inc Filings

Document Form Filing Date
No Filing Data

Meridian Bioscience Inc Analysis

Share your research

Headlines

See More
No news.